Does anyone know about any follow up study to the below outcome
Exenatide once weekly versus placebo in P... - Cure Parkinson's
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
Iqbal
I asked about Exenatide trial from my neurologist on a routine appointment last week and he said that the trial faced some financial problems and no pharmaceutical company wanted to accept the risk since they are getting enough profits with selling the drug to diabetic patients.
Thanks for sharing this. It's unfortunate that we are at the mercy of big pharma
Hi iqbaliqbal, this should be of concern to Ian Frizell who has been battling, unsuccessfully so far, to get his need to try Exenatide recognized.
Not what you're looking for?
You may also like...
A randomised, double-blind, placebo-controlled clinical trial of Zishenpingchan granules
Results demonstrated that Zishenpingchan granules significantly reduced the occurrence of motor...
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3)
https://clinicaltrials.gov/ct2/show/NCT04232969
Wondering if anyone on this forum has been taking...
Mucuna Pruriens in Parkinson's disease, dosages and effects, A double-blind, randomized, controlled, crossover human study (2017)
Mucuna pruriens in Parkinson disease. A double-blind, randomized, controlled, crossover study...
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
sounds promising what do you think?...
Hot off the press. Randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.
Open access
Published: 28 November 2023
Abstract
Nicotinamide adenine dinucleotide (NAD)...